T1	Artificial_process 1288 1297	treatment
T5	Disorder 862 864	MM
T9	Disorder 353 355	MM
T14	GGPs 738 743	LATS1
T18	GGPs 1403 1406	TAZ
T21	Disorder 1463 1470	disease
T27	Anatomical_entity 183 190;205 213	pleural cavities
T30	Disorder 670 673	MMs
T33	Disorder 97 119	Malignant mesothelioma
T38	GGPs 971 974;975 1003	TAZ transcriptional coactivators
T40	GGPs 558 566	NF2 gene
T42	GGPs 1092 1097	genes
T44	Negation_cue 476 485	very rare
T49	GGPs 390 393	ARF
T51	GGPs 772 778	merlin
T52	Molecular_function 366 375	mutations
T60	Artificial_process 544 549	treat
T61	Disorder 550 552	MM
T62	GGPs 1398 1402	YAP1
T69	GGPs 1081 1084	TAZ
T73	GGPs 1132 1136	CTGF
T74	Molecular_function 462 471	mutations
T77	Disorder 121 123	MM
T78	GGPs 395 398	NF2
T79	Disorder 155 160	tumor
T87	Anatomical_entity 194 213	peritoneal cavities
T88	Pathway 772 792	merlin-Hippo pathway
T89	Positive_regulation 924 930	result
T91	Cell 1048 1065	mesothelial cells
T92	GGPs 575 581	merlin
T100	Disorder 72 94	Malignant Mesothelioma
T102	Disorder 1301 1303	MM
E1	Artificial_process:T1 disorder:T102
E9	Molecular_function:T52 Theme:T82
E13	Artificial_process:T60 disorder:T61
E14	Molecular_function:T74 Cue:T44
E18	Pathway:T88 Participant:T107 Participant2:T51
E19	Positive_regulation:T89 Cause:E28 Theme:E25 Cue:T34
N9	Reference E1 UMLS:C0087111	Therapeutic procedure
N22	Reference T5 UMLS:C0345967	Malignant mesothelioma
N34	Reference T9 UMLS:C0345967	Malignant mesothelioma
N51	Reference T14 UMLS:C1259016	LATS1 protein, human
N66	Reference T18 UMLS:C2973330	WWTR1 protein, human
N73	Reference T21 UMLS:C0012634	Disease
N108	Reference T33 UMLS:C0345967	Malignant mesothelioma
N131	Reference T38 UMLS:C2973330	WWTR1 protein, human
N136	Reference T40 UMLS:C0085114	NF2 gene
N139	Reference T42 UMLS:C0017337	Genes
N175	Reference E9 UMLS:C0026882	Mutation
N200	Reference E13 UMLS:C0087111	Therapeutic procedure
N203	Reference T61 UMLS:C0345967	Malignant mesothelioma
N230	Reference T69 UMLS:C2973330	WWTR1 protein, human
N244	Reference E14 UMLS:C0026882	Mutation
N251	Reference T77 UMLS:C0345967	Malignant mesothelioma
N262	Reference T79 UMLS:C0027651	Neoplasms
N310	Reference T91 UMLS:C0225335	Mesothelial cell
N335	Reference T100 UMLS:C0345967	Malignant mesothelioma
N340	Reference T102 UMLS:C0345967	Malignant mesothelioma
N1	Reference T30 UMLS:C0345967	Malignant mesothelioma
T104	GGPs 14 19	Hippo
N5	Reference T104 UMLS:C3711343	Hippo protein, human
T105	GGPs 655 660	Hippo
N8	Reference T105 UMLS:C3711343	Hippo protein, human
T106	GGPs 703 708	Hippo
N11	Reference T106 UMLS:C3711343	Hippo protein, human
T107	GGPs 779 784	Hippo
N14	Reference T107 UMLS:C3711343	Hippo protein, human
T108	GGPs 879 884	Hippo
N15	Reference T108 UMLS:C3711343	Hippo protein, human
T109	GGPs 1242 1247	Hippo
N17	Reference T109 UMLS:C3711343	Hippo protein, human
T82	GGPs 383 389	CDKN2A
N19	Reference T82 UMLS:C0525037	CDKN2A gene
N21	Reference T49 UMLS:C0525037	CDKN2A gene
N23	Reference T78 UMLS:C0085114	NF2 gene
T110	GGPs 404 408	BAP1
N24	Reference T110 UMLS:C1332380	BAP1 gene
N26	Reference T92 UMLS:C0254123	Neurofibromin 2
N28	Reference T51 UMLS:C0254123	Neurofibromin 2
T36	GGPs 738 742;744 745	LATS 2
N32	Reference T36 UMLS:C0913413	LATS2 protein, human
T112	GGPs 966 970;975 1003	YAP1 transcriptional coactivators
N33	Reference T112 UMLS:C1318127	YAP1 protein, human
T113	GGPs 1076 1080	YAP1
N35	Reference T113 UMLS:C1318127	YAP1 protein, human
N36	Reference T62 UMLS:C1318127	YAP1 protein, human
N39	Reference T73 UMLS:C1413791	CTGF gene
N20	Reference T27 UMLS:C0178802	Pleural cavity
N41	Reference T87 UMLS:C1704247	Peritoneal Cavity
T4	Pathway 14 27	Hippo Pathway
E4	Pathway:T4 Participant:T104
N47	Reference E4 UMLS:C3158583	hippo signaling
T12	Pathway 655 668	Hippo pathway
E16	Pathway:T12 Participant:T105
N50	Reference E16 UMLS:C3158583	hippo signaling
T16	Pathway 703 716	Hippo pathway
E20	Pathway:T16 Participant:T106 Participant2:T14 Participant3:T36
N53	Reference E20 UMLS:C3158583	hippo signaling
T20	Pathway 879 892	Hippo pathway
E23	Pathway:T20 Participant:T108
N54	Reference E23 UMLS:C3158583	hippo signaling
T31	Pathway 1242 1255	Hippo pathway
E24	Pathway:T31 Participant:T109
T39	Positive_regulation 948 958	activation
E25	Positive_regulation:T39 Theme:T38
N58	Reference E25 UMLS:C1879547	Activation action
T41	Positive_regulation 1162 1169	enhance
E26	Positive_regulation:T41 Cause:T73 Theme:T11 Cue:T35
N59	Reference E26 UMLS:C1879547	Activation action
T47	Negative_regulation 687 699	inactivation
E27	Negative_regulation:T47 Theme:T14
N60	Reference E27 UMLS:C3463820	Inhibition
T58	Negative_regulation 893 905	inactivation
E28	Negative_regulation:T58 Theme:E23
N61	Reference E28 UMLS:C3463820	Inhibition
T23	Positive_regulation 598 607	regulates
E29	Positive_regulation:T23 Cause:T92 Theme:E16
N62	Reference E29 UMLS:C1879547	Activation action
E30	Negative_regulation:T47 Theme:T36 disorder:T30
N64	Reference E30 UMLS:C3463820	Inhibition
E32	Positive_regulation:T39 Theme:T112
N65	Reference E32 UMLS:C1879547	Activation action
T22	GGPs 453 461	oncogene
N68	Reference T22 UMLS:C0029016	Oncogenes
T3	Positive_regulation 442 452	activating
E2	Positive_regulation:T3 Cause:E14 Theme:T22
N16	Reference E2 UMLS:C1879547	Activation action
T66	Correlation 302 312	associated
E35	Correlation:T66 Theme:E31 Theme2:E33
T96	Regulation 807 823	plays a key role
E36	Regulation:T96 Theme:E3 Cause:E6 Cue:T25
N72	Reference E36 UMLS:C1327622	Regulation of biological process
T68	Biological_process 847 858	progression
E37	Biological_process:T68 Theme:T5
N74	Reference E37 UMLS:C0242656	Disease Progression
N75	Reference E19 UMLS:C1879547	Activation action
E38	Positive_regulation:T89 Cause:E28 Theme:E32 Cue:T34
N76	Reference E38 UMLS:C1879547	Activation action
T55	Molecular_function 278 297	genetic alterations
E31	Molecular_function:T55 
T75	Biological_process 338 349	progression
E33	Biological_process:T75 Theme:T9
N67	Reference E33 UMLS:C0242656	Disease Progression
E34	Molecular_function:T52 Theme:T78
N18	Reference E34 UMLS:C0026882	Mutation
E39	Molecular_function:T52 Theme:T110
N25	Reference E39 UMLS:C0026882	Mutation
T24	Pathway 617 640	cell-signaling cascades
E41	Pathway:T24 
N40	Reference E41 UMLS:C0037080	Signal Pathways
R3	member_of Arg1:E16 Arg2:E41	
T7	GGPs 409 431	tumor-suppressor genes
N2	Reference T7 UMLS:C0079427	Tumor Suppressor Genes
R4	member_of Arg1:T82 Arg2:T7	
R5	member_of Arg1:T78 Arg2:T7	
R6	member_of Arg1:T110 Arg2:T7	
N29	Reference E35 UMLS:C0332281	Associated with
R7	member_of Arg1:E39 Arg2:E31	
R8	member_of Arg1:E34 Arg2:E31	
R9	member_of Arg1:E9 Arg2:E31	
T10	Cell 1174 1206	malignant phenotypes of MM cells
N38	Reference T10 UMLS:C0345967	Malignant mesothelioma
T11	Disorder 1174 1206	malignant phenotypes of MM cells
N49	Reference T11 UMLS:C0345967	Malignant mesothelioma
T15	Localization 166 172	arises
E5	Localization:T15 Theme:T33 atLoc:T27
N56	Reference E5 UMLS:C1709305	Occur (action)
E8	Localization:T15 Theme:T33 atLoc:T27
N57	Reference E8 UMLS:C1709305	Occur (action)
N63	Reference E31 UMLS:C0262496	Molecular Abnormality
N44	Reference E24 UMLS:C3158583	hippo signaling
T29	Biological_process 831 842	development
E3	Biological_process:T29 Theme:T5
N46	Reference E3 UMLS:C0699748	Pathogenesis
T32	Biological_process 322 333	development
E10	Biological_process:T32 
N52	Reference E10 UMLS:C0699748	Pathogenesis
T19	Negative_regulation 793 806	dysregulation
E6	Negative_regulation:T19 Theme:E18
N7	Reference E6 UMLS:C3463820	Inhibition
E7	Regulation:T96 Cause:E6 Theme:E37 Cue:T25
N12	Reference E7 UMLS:C1327622	Regulation of biological process
A1	Negated E14
T25	Speculation_cue 756 766	suggesting
A2	Speculated E7
A3	Speculated E36
T34	Speculation_cue 915 920	shown
A4	Speculated E38
A5	Speculated E19
T35	Speculation_cue 1153 1158	shown
A6	Speculated E26
N27	Reference E18 UMLS:C0037080	Signal Pathways
